OSI Pharmaceuticals Cuts Boulder Plant

New York-based OSI Pharmaceuticals, a developer of oncology products, said this week that it is planning to shut its Boulder, Colorado operations later this year, as it consolidates its operations into a location in Westchester County, New York. The firm, which is also closing two facilities elsewhere in New York, plus an operation in New Jersey, said that approximately 350 employees will be affected across its four locations. The firm did not say how many of its Boulder employees would be offered a move into its new location.